These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

718 related items for PubMed ID: 29792038

  • 21. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.
    Cheung PF, Cheung TT, Yip CW, Ng LW, Fung SW, Lo CM, Fan ST, Cheung ST.
    Oncotarget; 2016 Apr 19; 7(16):21644-57. PubMed ID: 26942873
    [Abstract] [Full Text] [Related]

  • 22. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
    Martins-Neves SR, Paiva-Oliveira DI, Fontes-Ribeiro C, Bovée JVMG, Cleton-Jansen AM, Gomes CMF.
    Cancer Lett; 2018 Feb 01; 414():1-15. PubMed ID: 29126913
    [Abstract] [Full Text] [Related]

  • 23. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F, Yin LX.
    Exp Mol Pathol; 2019 Feb 01; 106():34-43. PubMed ID: 30539797
    [Abstract] [Full Text] [Related]

  • 24. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS, Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, Jin H, Choy KW, Yu J, To KF, Wong N, Huang TH, Sung JJ.
    Cancer Res; 2011 Jun 01; 71(11):4028-39. PubMed ID: 21512140
    [Abstract] [Full Text] [Related]

  • 25. lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal.
    Zhu P, Wang Y, Huang G, Ye B, Liu B, Wu J, Du Y, He L, Fan Z.
    Nat Struct Mol Biol; 2016 Jul 01; 23(7):631-9. PubMed ID: 27239797
    [Abstract] [Full Text] [Related]

  • 26. Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/β-catenin signaling in hepatocellular carcinoma.
    Lin X, Chen J, Li X, Chen D, Luo K, Deng Y, Yang D, Huang Z, Tao C.
    Arch Toxicol; 2023 Jun 01; 97(6):1627-1647. PubMed ID: 37120773
    [Abstract] [Full Text] [Related]

  • 27. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB, Lim JJ, Hooi L, Rashid MBMA, Chow EK.
    J Hepatol; 2020 Jan 01; 72(1):104-118. PubMed ID: 31541681
    [Abstract] [Full Text] [Related]

  • 28. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.
    Yuan J, Han B, Hu H, Qian Y, Liu Z, Wei Z, Liang X, Jiang B, Shao C, Gong Y.
    J Pathol; 2015 Apr 01; 235(5):784-95. PubMed ID: 25430888
    [Abstract] [Full Text] [Related]

  • 29. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J, Lai W, Li Q, Yu Y, Jin J, Guo W, Zhou X, Liu X, Wang Y.
    Biochem Biophys Res Commun; 2017 Sep 16; 491(2):469-477. PubMed ID: 28698142
    [Abstract] [Full Text] [Related]

  • 30. Krüppel-like factor 8 promotes cancer stem cell-like traits in hepatocellular carcinoma through Wnt/β-catenin signaling.
    Shen YN, He HG, Shi Y, Cao J, Yuan JY, Wang ZC, Shi CF, Zhu N, Wei YP, Liu F, Huang JL, Yang GS, Lu JH.
    Mol Carcinog; 2017 Feb 16; 56(2):751-760. PubMed ID: 27478926
    [Abstract] [Full Text] [Related]

  • 31. Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma.
    Wang C, Wang MD, Cheng P, Huang H, Dong W, Zhang WW, Li PP, Lin C, Pan ZY, Wu MC, Zhou WP.
    Cell Death Dis; 2017 Jan 19; 8(1):e2560. PubMed ID: 28102846
    [Abstract] [Full Text] [Related]

  • 32. 6-Shogaol Suppresses the Progression of Liver Cancer via the Inactivation of Wnt/[Formula: see text]-Catenin Signaling by Regulating TLR4.
    Zhang Y, Wang J, Qu Y, Chen Y.
    Am J Chin Med; 2021 Jan 19; 49(8):2033-2048. PubMed ID: 34961414
    [Abstract] [Full Text] [Related]

  • 33. Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit.
    Lin CS, Bamodu OA, Kuo KT, Huang CM, Liu SC, Wang CH, Tzeng YM, Chao TY, Yeh CT.
    Phytomedicine; 2018 Jul 15; 46():93-103. PubMed ID: 30097127
    [Abstract] [Full Text] [Related]

  • 34. Babao Dan is a robust anti-tumor agent via inhibiting wnt/β-catenin activation and cancer cell stemness.
    Xie X, Chen J, Wo D, Ma E, Ning Y, Peng J, Zhu W, Ren DN.
    J Ethnopharmacol; 2021 Nov 15; 280():114449. PubMed ID: 34332067
    [Abstract] [Full Text] [Related]

  • 35. EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
    Leung HW, Leung CON, Lau EY, Chung KPS, Mok EH, Lei MML, Leung RWH, Tong M, Keng VW, Ma C, Zhao Q, Ng IOL, Ma S, Lee TK.
    Cancer Res; 2021 Jun 15; 81(12):3229-3240. PubMed ID: 33903122
    [Abstract] [Full Text] [Related]

  • 36. Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling.
    Lei ZJ, Wang J, Xiao HL, Guo Y, Wang T, Li Q, Liu L, Luo X, Fan LL, Lin L, Mao CY, Wang SN, Wei YL, Lan CH, Jiang J, Yang XJ, Liu PD, Chen DF, Wang B.
    Oncogene; 2015 Jun 11; 34(24):3188-98. PubMed ID: 25893304
    [Abstract] [Full Text] [Related]

  • 37. Jiedu Recipe, a compound Chinese herbal medicine, inhibits cancer stemness in hepatocellular carcinoma via Wnt/β-catenin pathway under hypoxia.
    Guo BJ, Ruan Y, Wang YJ, Xiao CL, Zhong ZP, Cheng BB, Du J, Li B, Gu W, Yin ZF.
    J Integr Med; 2023 Sep 11; 21(5):474-486. PubMed ID: 37453868
    [Abstract] [Full Text] [Related]

  • 38. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC, Tung SL, Chen YL, Chen PM, Chu PY.
    BMC Cancer; 2018 May 30; 18(1):609. PubMed ID: 29848298
    [Abstract] [Full Text] [Related]

  • 39. Bruceine D inhibits hepatocellular carcinoma growth by targeting β-catenin/jagged1 pathways.
    Cheng Z, Yuan X, Qu Y, Li X, Wu G, Li C, Zu X, Yang N, Ke X, Zhou J, Xie N, Xu X, Liu S, Shen Y, Li H, Zhang W.
    Cancer Lett; 2017 Sep 10; 403():195-205. PubMed ID: 28645563
    [Abstract] [Full Text] [Related]

  • 40. Ovatodiolide suppresses yes-associated protein 1-modulated cancer stem cell phenotypes in highly malignant hepatocellular carcinoma and sensitizes cancer cells to chemotherapy in vitro.
    Chang HL, Chen HA, Bamodu OA, Lee KF, Tzeng YM, Lee WH, Tsai JT.
    Toxicol In Vitro; 2018 Sep 10; 51():74-82. PubMed ID: 29698666
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.